Burcon NutraScience Corporation
BRCNF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -25.1% | 699% | -30.4% | – |
| Cost of Goods Sold | $2 | $2 | $1 | $0 |
| Gross Profit | -$2 | -$1 | -$1 | -$0 |
| % Margin | -680.2% | -419.2% | -1,283.5% | -367.3% |
| R&D Expenses | $0 | $0 | $0 | $1 |
| G&A Expenses | $0 | $1 | $1 | $1 |
| SG&A Expenses | $0 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | -$0 |
| Operating Expenses | $0 | $1 | $1 | $2 |
| Operating Income | -$2 | -$2 | -$2 | -$2 |
| % Margin | -823.3% | -723.4% | -4,531.3% | -2,913.4% |
| Other Income/Exp. Net | -$0 | -$1 | -$0 | $0 |
| Pre-Tax Income | -$3 | -$3 | -$2 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$3 | -$2 | -$2 |
| % Margin | -1,005.9% | -1,015.5% | -5,268.8% | -2,901.1% |
| EPS | -0.2 | -0.27 | -0.23 | -0.25 |
| % Growth | 25.9% | -17.4% | 8% | – |
| EPS Diluted | -0.2 | -0.27 | -0.23 | -0.25 |
| Weighted Avg Shares Out | 13 | 13 | 10 | 7 |
| Weighted Avg Shares Out Dil | 13 | 13 | 10 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$2 | -$2 | -$2 |
| % Margin | -584.8% | -704.1% | -4,416.9% | -2,795.9% |